What is the Future of Epigenetic Biomarkers in Toxicology?
The future of epigenetic biomarkers in toxicology is promising, with advancements in high-throughput sequencing and bioinformatics allowing for more comprehensive and precise analyses. As our understanding of the epigenome expands, these biomarkers will likely play an increasingly important role in public health, environmental policy, and personalized medicine.
In conclusion, epigenetic biomarkers offer a powerful tool in toxicology, providing insights into how environmental exposures can influence health at the molecular level. Despite current challenges, ongoing research continues to unlock their potential, paving the way for more precise exposure assessments, risk evaluations, and therapeutic strategies.
